Furthermore, elevated levels of CXCL13 have been reported in the cerebrospinal fluid (CSF), active plaques, and meningeal ectopic follicles of patients with multiple sclerosis (MS), and thus, is considered to be a biomarker for MS and other neuroinflammatory diseases (33, 34, 46). This evidence concerns the gene CXCL13 and multiple sclerosis.